Research and Markets: Out Now - CNS Drug Discoveries: Parkinson's Disease Chapter
Monday September 1, 5:38 am ET
http://biz.yahoo.com/bw/080901/20080901005119.html?.v=1
Key PD questions answered include:
- What percentage of the treatable population for PD has been diagnosed in Europe, US and Japan?
- Which PD products will face generic challenges by 2014?
- What are the commercial prospects for Bayer’s revolutionary disease-modifying agent spheramine?
- By 2014, Boehringer Ingelheim and GSK will have lost considerable PD marke
t share – to whom and what products will make the difference?